This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: RIMM AIG AOL JCP FRX

Oasis Petroleum (OAS) upgraded at Wells Fargo to outperform from market perform, Wells Fargo said. $40 to $45 valuation range. Strong operational momentum.

Principal Financial (PFG) downgraded at UBS to sell from neutral, UBS said. $27 price target. Accumulation business to remain under pressure.

Philip Morris (PM) upgraded at Goldman from neutral to buy, Goldman Sachs said. $103 price target. Company was also placed on the Conviction Buy list. Company offers growth and yield at an attractive valuation.

Pepco (POM) downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. $20.50 price target. Company is facing multiple growth headwinds.

Perrigo (PRGO) downgraded at Goldman from neutral to sell, Goldman Sachs said. $110 price target. Growth could slow in the next few quarters.

Research in Motion (RIMM) downgraded at BMO to underperform, BMO Capital said. $9 price target. New BB10 phones will likely not stem market share losses.

JM Smucker (SJM) downgraded at Goldman from buy to neutral, Goldman Sachs said. Valuation call, based on a $93 price target.

SodaStream International (SODA) rated new buy at Citigroup. $60 price target. Skeptics abound but momentum is hard to dispute.

Standard Pacific (SPF) downgraded at JP Morgan from neutral to underweight, JP Morgan said. Valuation call, as the stock trades at a 35% premium to its peers.

Molson Coors (TAP) rated new buy at Nomura. $54 price target. Investor sentiment is too low and the company can continue to cut costs.

Tenet Healthcare (THC) upgraded at BofA/Merrill from neutral to buy, Bank of America/Merrill Lynch said. $44 price target. Company is improving margins and leveraging its balance sheet.

Targa Resources (TRGP) downgraded at BofA to neutral from buy, Bank of America Merrill Lynch said. $60 price target. Valuation call.

Watson Pharmaceuticals (WPI) downgraded at Goldman from buy to neutral, Goldman Sachs said. $96 price target. Valuation call, as the stock gained 43% in 2012.

Watsco (WSO) downgraded at JP Morgan to underweight, JP Morgan said. Valuation call, based on a $72 price target.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FRX $99.00 -0.77%
AIG $57.43 0.00%
AOL $39.95 0.00%
JCP $8.71 0.00%
AAPL $124.75 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs